These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22798680)

  • 1. CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17-polarizing conditions.
    Tsai JP; Lee MH; Hsu SC; Chen MY; Liu SJ; Chang JT; Liao CT; Cheng AJ; Chong P; Chu CL; Shen CR; Chen HW
    J Immunol; 2012 Aug; 189(4):1671-9. PubMed ID: 22798680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of Th17/Tc17 and Th17/Treg cells in endometrial carcinoma.
    Zhang W; Hou F; Zhang Y; Tian Y; Jiao J; Ma D; Kong B; Cui B
    Gynecol Oncol; 2014 Mar; 132(3):599-605. PubMed ID: 24388919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
    Kuang DM; Peng C; Zhao Q; Wu Y; Zhu LY; Wang J; Yin XY; Li L; Zheng L
    J Immunol; 2010 Aug; 185(3):1544-9. PubMed ID: 20581151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.
    Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Chen W; Pang KC; Liu XF; Liu T; Zhang JY; Zeng H; Liu KY; Guo G; Tong WD; Shi Y; Tang B; Li N; Yu S; Luo P; Zhang WJ; Lu DS; Yu PW; Zou QM
    Gastroenterology; 2012 Oct; 143(4):951-62.e8. PubMed ID: 22710190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.
    Lee JJ; Chang YL; Lai WL; Ko JY; Kuo MY; Chiang CP; Azuma M; Chen CW; Chia JS
    Head Neck; 2011 Sep; 33(9):1301-8. PubMed ID: 21837700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
    Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
    Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
    Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
    Liu SJ; Tsai JP; Shen CR; Sher YP; Hsieh CL; Yeh YC; Chou AH; Chang SR; Hsiao KN; Yu FW; Chen HW
    J Leukoc Biol; 2007 Aug; 82(2):354-60. PubMed ID: 17505023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains.
    Wang J; Han WG; Foks AC; Huizinga TW; Toes RE
    Mol Immunol; 2010; 48(1-3):137-46. PubMed ID: 20869773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.
    Trzonkowski P; Szmit E; Myśliwska J; Dobyszuk A; Myśliwski A
    Clin Immunol; 2004 Sep; 112(3):258-67. PubMed ID: 15308119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.